idazoxan has been researched along with Adipocere in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dean, B | 1 |
| Greenup, JL; Leverenz, JB; Peskind, ER; Raskind, MA; Szot, P; White, SS | 1 |
| Gargalidis-Moudanos, C; Javoy-Agid, F; Parini, A; Pizzinat, N; Remaury, A | 1 |
3 other study(ies) available for idazoxan and Adipocere
| Article | Year |
|---|---|
[3H]RX 821002 in human dorsolateral prefrontal cortex: no changes in postmortem tissue from subjects with schizophrenia.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Adult; Aged; Benzodiazepines; Binding Sites; Clozapine; Female; Hippocampus; Humans; Idazoxan; Male; Middle Aged; Olanzapine; Postmortem Changes; Prefrontal Cortex; Schizophrenia; Serotonin Antagonists | 2003 |
Changes in adrenoreceptors in the prefrontal cortex of subjects with dementia: evidence of compensatory changes.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Dementia; Female; Gene Expression Regulation; Humans; Idazoxan; Male; Middle Aged; Postmortem Changes; Prazosin; Prefrontal Cortex; Receptors, Adrenergic; RNA, Messenger | 2007 |
I2-imidazoline binding sites and monoamine oxidase activity in human postmortem brain from patients with Parkinson's disease.
Topics: Aged; Aged, 80 and over; Brain; Cerebral Cortex; Female; Humans; Idazoxan; Imidazoline Receptors; Male; Mitochondria; Monoamine Oxidase; Parkinson Disease; Phenethylamines; Postmortem Changes; Putamen; Receptors, Drug; Tritium; Tyramine | 1997 |